Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1802 1
1825 1
1841 1
1911 1
1920 1
1940 1
1946 3
1947 5
1948 2
1949 1
1950 1
1953 3
1954 2
1955 4
1956 3
1959 1
1960 2
1961 2
1962 4
1963 1
1964 1
1968 2
1970 2
1971 1
1972 1
1973 1
1975 4
1976 5
1977 5
1978 3
1979 2
1980 3
1981 2
1982 6
1983 8
1984 12
1985 9
1986 10
1987 9
1988 11
1989 21
1990 25
1991 20
1992 31
1993 30
1994 30
1995 35
1996 39
1997 55
1998 48
1999 40
2000 42
2001 29
2002 33
2003 45
2004 24
2005 46
2006 29
2007 21
2008 11
2009 17
2010 15
2011 15
2012 15
2013 23
2014 29
2015 32
2016 31
2017 41
2018 81
2019 172
2020 182
2021 15
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 11694665

1,402 results
Results by year
Filters applied: . Clear all
Page 1
Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.
Salmaso S, Mastrantonio P, Tozzi AE, Stefanelli P, Anemona A, Ciofi degli Atti ML, Giammanco A; Stage III Working Group. Salmaso S, et al. Pediatrics. 2001 Nov;108(5):E81. doi: 10.1542/peds.108.5.e81. Pediatrics. 2001. PMID: 11694665 Clinical Trial.
Clinical presentation of pertussis in unvaccinated and vaccinated children in the first six years of life.
Tozzi AE, Ravà L, Ciofi degli Atti ML, Salmaso S; Progetto Pertosse Working Group. Tozzi AE, et al. Pediatrics. 2003 Nov;112(5):1069-75. doi: 10.1542/peds.112.5.1069. Pediatrics. 2003. PMID: 14595048 Clinical Trial.
Cell-mediated and antibody responses to Bordetella pertussis antigens in children vaccinated with acellular or whole-cell pertussis vaccines. The Progetto Pertosse-CMI Working Group.
Cassone A, Ausiello CM, Urbani F, Lande R, Giuliano M, La Sala A, Piscitelli A, Salmaso S. Cassone A, et al. Arch Pediatr Adolesc Med. 1997 Mar;151(3):283-9. doi: 10.1001/archpedi.1997.02170400069013. Arch Pediatr Adolesc Med. 1997. PMID: 9080938 Clinical Trial.
Reactogenicity and immunogenicity at preschool age of a booster dose of two three-component diphtheria-tetanus-acellular pertussis vaccines in children primed in infancy with acellular vaccines.
Tozzi AE, Anemona A, Stefanelli P, Salmaso S, Ciofi degli Atti ML, Mastrantonio P, Giammanco A; Progetto Pertosse Study Group. Tozzi AE, et al. Pediatrics. 2001 Feb;107(2):E25. doi: 10.1542/peds.107.2.e25. Pediatrics. 2001. PMID: 11158499 Clinical Trial.
A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccine.
Stehr K, Cherry JD, Heininger U, Schmitt-Grohé S, uberall M, Laussucq S, Eckhardt T, Meyer M, Engelhardt R, Christenson P. Stehr K, et al. Pediatrics. 1998 Jan;101(1 Pt 1):1-11. doi: 10.1542/peds.101.1.1. Pediatrics. 1998. PMID: 9417143 Clinical Trial.
Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
Bisgard KM, Rhodes P, Connelly BL, Bi D, Hahn C, Patrick S, Glodé MP, Ehresmann KR; Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. kbisgard@cdc.gov. Bisgard KM, et al. Pediatrics. 2005 Aug;116(2):e285-94. doi: 10.1542/peds.2004-2759. Pediatrics. 2005. PMID: 16061582
Diphtheria-tetanus-acellular pertussis vaccine adsorbed (Triacelluvax; DTaP3-CB): a review of its use in the prevention of Bordetella pertussis infection.
Matheson AJ, Goa KL. Matheson AJ, et al. Paediatr Drugs. 2000 Mar-Apr;2(2):139-59. doi: 10.2165/00148581-200002020-00007. Paediatr Drugs. 2000. PMID: 10937466 Review.
A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children.
Pichichero ME, Deloria MA, Rennels MB, Anderson EL, Edwards KM, Decker MD, Englund JA, Steinhoff MC, Deforest A, Meade BD. Pichichero ME, et al. Pediatrics. 1997 Nov;100(5):772-88. doi: 10.1542/peds.100.5.772. Pediatrics. 1997. PMID: 9346976 Clinical Trial.
Persistence of protection through 33 months of age provided by immunization in infancy with two three-component acellular pertussis vaccines. Stage II Working Group.
Salmaso S, Mastrantonio P, Wassilak SG, Giuliano M, Anemona A, Giammanco A, Tozzi AE, Ciofi degli Atti ML, Greco D. Salmaso S, et al. Vaccine. 1998 Aug;16(13):1270-5. doi: 10.1016/s0264-410x(98)00040-1. Vaccine. 1998. PMID: 9682390 Clinical Trial.
1,402 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback